Literature DB >> 15722328

Brinzolamide induced reversible corneal decompensation.

J C Zhao, T Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15722328      PMCID： PMC1772558          DOI： 10.1136/bjo.2004.049544

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Irreversible corneal decompensation in patients treated with topical dorzolamide.

Authors:  I Adamsons
Journal:  Am J Ophthalmol       Date:  1999-12       Impact factor: 5.258

2.  Irreversible corneal decompensation in patients treated with topical dorzolamide.

Authors:  A Konowal; J C Morrison; S V Brown; D L Cooke; L J Maguire; D V Verdier; F T Fraunfelder; R F Dennis; R J Epstein
Journal:  Am J Ophthalmol       Date:  1999-04       Impact factor: 5.258

3.  Central corneal endothelial cell changes over a ten-year period.

Authors:  W M Bourne; L R Nelson; D O Hodge
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-03       Impact factor: 4.799

4.  A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group.

Authors:  J H Lass; S A Khosrof; J K Laurence; B Horwitz; K Ghosh; I Adamsons
Journal:  Arch Ophthalmol       Date:  1998-08

5.  Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.

Authors:  Matthias G Wirtitsch; Oliver Findl; Barbara Kiss; Vanessa Petternel; Harald Heinzl; Wolfgang Drexler
Journal:  Arch Ophthalmol       Date:  2003-05
  5 in total
  6 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

2.  Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors.

Authors:  Ana M Roldan; Nazlee Zebardast; Maxwell Pistilli; Naira Khachatryan; Abhishek Payal; Hosne Begum; Pichaporn Artornsombudh; Siddharth S Pujari; James T Rosenbaum; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; Jeanine M Buchanich; John H Kempen
Journal:  Am J Ophthalmol       Date:  2021-11-13       Impact factor: 5.258

3.  Two pediatric cases of reticular corneal epithelial edema associated with netarsudil.

Authors:  Maria A Guzman Aparicio; Daniel L Liebman; James Chodosh; Suzanne K Freitag; Melanie Kazlas; Derek D Mai; Catherine M Marando; Shizuo Mukai; Annie M Wu; Teresa C Chen
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-28

4.  CD147 required for corneal endothelial lactate transport.

Authors:  Shimin Li; Tracy T Nguyen; Joseph A Bonanno
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-26       Impact factor: 4.799

5.  Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension.

Authors:  Michele Iester
Journal:  Clin Ophthalmol       Date:  2008-09

Review 6.  A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications.

Authors:  Xiaoyu Zhou; Xinyue Zhang; Dengming Zhou; Yang Zhao; Xuanchu Duan
Journal:  Ophthalmol Ther       Date:  2022-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.